315 related articles for article (PubMed ID: 11478933)
1. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.
Jain NK; Patil CS; Singh A; Kulkarni SK
Brain Res; 2001 Aug; 909(1-2):170-8. PubMed ID: 11478933
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception.
Patil CS; Jain NK; Singh VP; Kulkarni SK
Indian J Exp Biol; 2004 Apr; 42(4):361-7. PubMed ID: 15088685
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine.
Jain NK; Patil CS; Singh A; Kulkarni SK
Pharmacology; 2003 Mar; 67(3):150-6. PubMed ID: 12571411
[TBL] [Abstract][Full Text] [Related]
4. The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway.
Riazi K; Roshanpour M; Rafiei-Tabatabaei N; Homayoun H; Ebrahimi F; Dehpour AR
Br J Pharmacol; 2006 Apr; 147(8):935-43. PubMed ID: 16474413
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception.
Patil CS; Jain NK; Singh A; Kulkarni SK
Pharmacology; 2003 Dec; 69(4):183-9. PubMed ID: 14624058
[TBL] [Abstract][Full Text] [Related]
6. Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.
Patil CS; Singh VP; Kulkarni SK
Inflammopharmacology; 2005; 13(5-6):467-78. PubMed ID: 16280099
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil induces hyperalgesia via activation of the NO-cGMP pathway in the rat neuropathic pain model.
Patil CS; Padi SV; Singh VP; Kulkarni SK
Inflammopharmacology; 2006 Mar; 14(1-2):22-7. PubMed ID: 16835709
[TBL] [Abstract][Full Text] [Related]
8. Rewarding properties of sildenafil citrate in mice: role of the nitric oxide-cyclic GMP pathway.
Tahsili-Fahadan P; Yahyavi-Firouz-Abadi N; Orandi AH; Esmaeili B; Basseda Z; Dehpour AR
Psychopharmacology (Berl); 2006 Apr; 185(2):201-7. PubMed ID: 16425058
[TBL] [Abstract][Full Text] [Related]
9. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway.
Amarante LH; Duarte ID
Eur J Pharmacol; 2002 Nov; 454(1):19-23. PubMed ID: 12409000
[TBL] [Abstract][Full Text] [Related]
10. Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy.
Patil CS; Singh VP; Singh S; Kulkarni SK
Pharmacology; 2004 Nov; 72(3):190-5. PubMed ID: 15452368
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester.
Devan BD; Pistell PJ; Daffin LW; Nelson CM; Duffy KB; Bowker JL; Bharati IS; Sierra-Mercado D; Spangler EL; Ingram DK
Eur J Pharmacol; 2007 Jun; 563(1-3):134-40. PubMed ID: 17362916
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice.
Akula KK; Dhir A; Kulkarni SK
Eur J Pharmacol; 2008 Jun; 587(1-3):129-34. PubMed ID: 18457833
[TBL] [Abstract][Full Text] [Related]
13. Relaxant effect of sildenafil in the rabbit basilar artery.
Salom JB; Burguete MC; Pérez-Asensio FJ; Castelló-Ruiz M; Torregrosa G; Alborch E
Vascul Pharmacol; 2006 Jan; 44(1):10-6. PubMed ID: 16325476
[TBL] [Abstract][Full Text] [Related]
14. Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats.
Medeiros JV; Gadelha GG; Lima SJ; Garcia JA; Soares PM; Santos AA; Brito GA; Ribeiro RA; Souza MH
Br J Pharmacol; 2008 Feb; 153(4):721-7. PubMed ID: 18071300
[TBL] [Abstract][Full Text] [Related]
15. Twenty-four-hour variation of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway demonstrated by the mouse visceral pain model.
Uludag O; Tunctan B; Altug S; Zengil H; Abacioglu N
Chronobiol Int; 2007; 24(3):413-24. PubMed ID: 17612941
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.
Das A; Xi L; Kukreja RC
J Biol Chem; 2005 Apr; 280(13):12944-55. PubMed ID: 15668244
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
[TBL] [Abstract][Full Text] [Related]
18. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
Duarte ID; Ferreira SH
Mediators Inflamm; 2000; 9(1):25-30. PubMed ID: 10877451
[TBL] [Abstract][Full Text] [Related]
19. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Araiza-Saldaña CI; Reyes-García G; Bermúdez-Ocaña DY; Pérez-Severiano F; Granados-Soto V
Eur J Pharmacol; 2005 Dec; 527(1-3):60-70. PubMed ID: 16305795
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum.
Takagi M; Mochida H; Noto T; Yano K; Inoue H; Ikeo T; Kikkawa K
Eur J Pharmacol; 2001 Jan; 411(1-2):161-168. PubMed ID: 11137871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
